Frespaciguat
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Frespaciguat, covering 2022-02-23 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD [Phase 2]